|
1
|
You Z, Al Kindi H, Abdul-Karim A, Barrette
PO and Schwertani A: Blocking the urotensin II receptor pathway
ameliorates the metabolic syndrome and improves cardiac function in
obese mice. FASEB J. 28:1210–1220. 2014. View Article : Google Scholar
|
|
2
|
Vaudry H, Leprince J, Chatenet D, Fournier
A, Lambert DG, Le Mével JC, Ohlstein EH, Schwertani A, Tostivint H
and Vaudry D: International Union of Basic and Clinical
Pharmacology. XCII Urotensin II, urotensin II-related peptide, and
their receptor: from structure to function. Pharmacol Rev.
67:214–258. 2015. View Article : Google Scholar
|
|
3
|
Forbes JM, Cooper ME, Oldfield MD and
Thomas MC: Role of advanced glycation end products in diabetic
nephropathy. J Am Soc Nephrol. 14(Suppl 3): S254–S258. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamagishi S: Role of advanced glycation
end products (AGEs) and receptor for AGEs (RAGE) in vascular damage
in diabetes. Exp Gerontol. 46:217–224. 2011. View Article : Google Scholar
|
|
5
|
Shenouda A, Douglas SA, Ohlstein EH and
Giaid A: Localization of urotensin-II immunoreactivity in normal
human kidneys and renal carcinoma. J Histochem Cytochem.
50:885–889. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hsu YH, Chen TH, Chen YC, Cheng CY, Sue
YM, Chen JR and Chen CH: Urotensin II exerts antiapoptotic effect
on NRK-52E cells through prostacyclin-mediated peroxisome
proliferator-activated receptor alpha and Akt activation. Mol Cell
Endocrinol. 381:168–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Totsune K, Takahashi K, Arihara Z, Sone M,
Ito S and Murakami O: Increased plasma urotensin II levels in
patients with diabetes mellitus. Clin Sci (Lond). 104:1–5. 2003.
View Article : Google Scholar
|
|
8
|
Xie N and Liu L: Elevated expression of
urotensin II and its receptor in great artery of type 2 diabetes
and its significance. Biomed Pharmacother. 63:734–741. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Langham RG, Kelly DJ, Gow RM, Zhang Y,
Dowling JK, Thomson NM and Gilbert RE: Increased expression of
urotensin II and urotensin II receptor in human diabetic
nephropathy. Am J Kidney Dis. 44:826–831. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lam S, van der Geest RN, Verhagen NA, Daha
MR and van Kooten C: Secretion of collagen type IV by human renal
fibroblasts is increased by high glucose via a TGF-beta-independent
pathway. Nephrol Dial Transplant. 19:1694–1701. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park JT, Kato M, Lanting L, Castro N, Nam
BY, Wang M, Kang SW and Natarajan R: Repression of let-7 by
transforming growth factor-β1-induced Lin28 upregulates collagen
expression in glomerular mesangial cells under diabetic conditions.
Am J Physiol Renal Physiol. 307:F1390–F1403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dai HY, Kang WQ, Wang X, Yu XJ, Li ZH,
Tang MX, Xu DL, Li CW, Zhang Y and Ge ZM: The involvement of
transforming growth factor-beta1 secretion in urotensin II-induced
collagen synthesis in neonatal cardiac fibroblasts. Regul Pept.
140:88–93. 2007. View Article : Google Scholar
|
|
13
|
Coulouarn Y, Lihrmann I, Jegou S, Anouar
Y, Tostivint H, Beauvillain JC, Conlon JM, Bern HA and Vaudry H:
Cloning of the cDNA encoding the urotensin II precursor in frog and
human reveals intense expression of the urotensin II gene in
motoneurons of the spinal cord. Proc Natl Acad Sci USA.
95:15803–15808. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ames RS, Sarau HM, Chambers JK, Willette
RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF,
Coatney RW, et al: Human urotensin-II is a potent vasoconstrictor
and agonist for the orphan receptor GPR14. Nature. 401:282–286.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matsushita M, Shichiri M, Imai T, Iwashina
M, Tanaka H, Takasu N and Hirata Y: Co-expression of urotensin II
and its receptor (GPR14) in human cardiovascular and renal tissues.
J Hypertens. 19:2185–2190. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang YG, Li YG, Liu BG, Wei RH, Wang DM,
Tan XR, Bu DF, Pang YZ and Tang CS: Urotensin II accelerates
cardiac fibrosis and hypertrophy of rats induced by isoproterenol.
Acta Pharmacol Sin. 28:36–43. 2007. View Article : Google Scholar
|
|
17
|
Guidolin D, Albertin G, Oselladore B,
Sorato E, Rebuffat P, Mascarin A and Ribatti D: The pro-angiogenic
activity of urotensin-II on human vascular endothelial cells
involves ERK1/2 and PI3K signaling pathways. Regul Pept. 162:26–32.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Albertin G, Guidolin D, Sorato E,
Oselladore B, Tortorella C and Ribatti D: Urotensin-II-stimulated
expression of pro-angiogenic factors in human vascular endothelial
cells. Regul Pept. 172:16–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sauzeau V, Le Mellionnec E, Bertoglio J,
Scalbert E, Pacaud P and Loirand G: Human urotensin II-induced
contraction and arterial smooth muscle cell proliferation are
mediated by RhoA and Rho-kinase. Circ Res. 88:1102–1104. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Watanabe T, Pakala R, Katagiri T and
Benedict CR: Synergistic effect of urotensin II with serotonin on
vascular smooth muscle cell proliferation. J Hypertens.
19:2191–2196. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsushita M, Shichiri M, Fukai N, Ozawa
N, Yoshimoto T, Takasu N and Hirata Y: Urotensin II is an
autocrine/paracrine growth factor for the porcine renal epithelial
cell line, LLCPK1. Endocrinology. 144:1825–1831. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takahashi K, Totsune K, Murakami O,
Arihara Z, Noshiro T, Hayashi Y and Shibahara S: Expression of
urotensin II and its receptor in adrenal tumors and stimulation of
proliferation of cultured tumor cells by urotensin II. Peptides.
24:301–306. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dai HY, He T, Li XL, Xu WL and Ge ZM:
Urotensin-2 promotes collagen synthesis via ERK1/2-dependent and
ERK1/2-independent TGF-β1 in neonatal cardiac fibroblasts. Cell
Biol Int. 35:93–98. 2011. View Article : Google Scholar
|
|
24
|
Xu S, Wen H and Jiang H: Urotensin II
promotes the proliferation of endothelial progenitor cells through
p38 and p44/42 MAPK activation. Mol Med Rep. 6:197–200.
2012.PubMed/NCBI
|
|
25
|
Adebiyi A: Rgs2 regulates urotensin
II-induced intracellular Ca2+ elevation and contraction
in glomerular mesangial cells. J Cell Physiol. 229:502–511. 2014.
View Article : Google Scholar
|
|
26
|
Fukami K, Ueda S, Yamagishi S, Kato S,
Inagaki Y, Takeuchi M, Motomiya Y, Bucala R, Iida S, Tamaki K, et
al: AGEs activate mesangial TGF-beta-Smad signaling via an
angiotensin II type I receptor interaction. Kidney Int.
66:2137–2147. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamagishi S, Fukami K, Ueda S and Okuda S:
Molecular mechanisms of diabetic nephropathy and its therapeutic
intervention. Curr Drug Targets. 8:952–959. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ishibashi Y, Matsui T, Takeuchi M and
Yamagishi S: Metformin inhibits advanced glycation end products
(AGEs)-induced renal tubular cell injury by suppressing reactive
oxygen species generation via reducing receptor for AGEs (RAGE)
expression. Horm Metab Res. 44:891–895. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eismann U, Sommer M, Kosmehl H, Appenroth
D, Fleck C and Stein G: Fibronectin splice variants-prognostic
markers for the stage of renal interstitial fibrosis in the rat.
Nephron. 92:379–388. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao J, Ding W, Song N, Dong X, Di B, Peng
F and Tang C: Urotensin II-induced collagen synthesis in cultured
smooth muscle cells from rat aortic media and a possible
involvement of transforming growth factor-β1/Smad2/3 signaling
pathway. Regul Pept. 182:53–58. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tian L, Li C, Qi J, Fu P, Yu X, Li X and
Cai L: Diabetes-induced upregulation of urotensin II and its
receptor plays an important role in TGF-beta1-mediated renal
fibrosis and dysfunction. Am J Physiol Endocrinol Metab.
295:E1234–E1242. 2008. View Article : Google Scholar : PubMed/NCBI
|
